Literature DB >> 34082964

Different hydration states and passive tumor targeting ability of polyethylene glycol-modified dendrimers with high and low PEG density.

Ayako Tsujimoto1, Hiroki Uehara2, Haruna Yoshida3, Misaki Nishio1, Kousuke Furuta3, Takashi Inui3, Akikazu Matsumoto1, Shigeaki Morita4, Masaru Tanaka2, Chie Kojima5.   

Abstract

It has been reported that the amount of intermediate water, defined as water molecules loosely bound to a material, is a useful index of the material's bio-inert properties. Polyethylene glycol (PEG) is a well-known biocompatible polymer with a large amount of intermediate water. Many researchers have showed that PEGylated nanoparticles are passively accumulated in tumor tissues owing to their enhanced permeability and retention (EPR) effects. Dendrimers are regularly branched polymers with highly controllable size and structure, which can be exploited as potent drug carriers. In this study, we investigated the tripartite relationship among the PEG density, the hydration state, and the passive tumor targeting property, using PEGylated dendrimers. The fully PEGylated dendrimer, PEG64-den, showed similar hydration behavior to PEG and a passive tumor targeting property. In contrast, the hydration state of the partly PEGylated dendrimer, PEG5-den, was different from that of PEG64-den, and the passive tumor targeting property was not observed. This is the first report to show the hydration state of a drug carrier as well as discuss a relationship between the hydration state and biodistribution.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dendrimer; Drug delivery system; Hydration; Passive targeting; Polyethylene glycol

Mesh:

Substances:

Year:  2021        PMID: 34082964     DOI: 10.1016/j.msec.2021.112159

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  4 in total

Review 1.  Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine.

Authors:  Xiang Li; Abid Naeem; Shanghua Xiao; Lei Hu; Jing Zhang; Qin Zheng
Journal:  Pharmaceutics       Date:  2022-06-17       Impact factor: 6.525

2.  Bilateral multifocal central serous retinopathy following mRNA COVID-19 vaccine.

Authors:  N Mechleb; Z Khoueir; A Assi
Journal:  J Fr Ophtalmol       Date:  2022-04-28       Impact factor: 1.194

Review 3.  Nanotechnology in the Diagnostic and Therapy of Hepatocellular Carcinoma.

Authors:  Florin Graur; Aida Puia; Emil Ioan Mois; Septimiu Moldovan; Alexandra Pusta; Cecilia Cristea; Simona Cavalu; Cosmin Puia; Nadim Al Hajjar
Journal:  Materials (Basel)       Date:  2022-05-30       Impact factor: 3.748

Review 4.  Recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapy.

Authors:  Sathish Sundar Dhilip Kumar; Heidi Abrahamse
Journal:  Front Chem       Date:  2022-08-15       Impact factor: 5.545

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.